HT90432
Safranin O solution
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.47
UNSPSC Code:
41116121
form
solution
Quality Level
shelf life
Expiry date on the label
IVD
for in vitro diagnostic use
concentration
0.6%
pH
8.5
application(s)
hematology
histology
storage temp.
room temp
Application
Intended for use in Sigma Gram Stain Procedure, HT90.
Other Notes
Certified safranin 0.6% in 20% ethyl alcohol, SD3A.
Still not finding the right product?
Explore all of our products under Safranin O solution
signalword
Warning
hcodes
Hazard Classifications
Flam. Liq. 3
Storage Class
3 - Flammable liquids
wgk
WGK 2
flash_point_f
100.0 °F - closed cup
flash_point_c
37.8 °C - closed cup
ppe
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Regulatory Information
监管及禁止进口产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Hye Jin Kim et al.
Biomaterials, 177, 1-13 (2018-06-09)
Overexpression and knockdown of specific proteins can control stem cell differentiation for therapeutic purposes. In this study, we fabricated RUNX2, SOX9, and C/EBPα plasmid DNAs (pDNAs) and ATF4-targeting shRNA (shATF4) to induce osteogenesis, chondrogenesis, and adipogenesis of human mesenchymal stem
Inhibition of integrative repair of the meniscus following acute exposure to interleukin-1 in vitro.
Rebecca E Wilusz et al.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 26(4), 504-512 (2007-12-01)
Damage or loss of the meniscus is associated with progressive osteoarthritic degeneration of the knee joint. Injured and degenerative joints are characterized by elevated levels of the pro-inflammatory cytokine interleukin-1 (IL-1), which with prolonged exposure can induce catabolic and anti-anabolic
Melissa N van Tok et al.
Arthritis & rheumatology (Hoboken, N.J.), 71(4), 612-625 (2018-11-06)
It remains unclear if and how inflammation and new bone formation in spondyloarthritis (SpA) are coupled. We undertook this study to assess the hypothesis that interleukin-17A (IL-17A) is a pivotal driver of both processes. The effect of tumor necrosis factor
Global Trade Item Number
| SKU | GTIN |
|---|---|
| HT90432-1L | 04061833835517 |